# Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Non-infectious and Idiopathic Uveitis

> **NCT04162314** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Fakultas Kedokteran Universitas Indonesia** · enrollment: 20 (estimated)

## Conditions studied

- Uveitis

## Interventions

- **DRUG:** Beta-1,3/1,6-D-Glucan Ganoderma lucidum
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT04162314
- **Lead sponsor:** Fakultas Kedokteran Universitas Indonesia
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-21
- **Primary completion:** 2021-09
- **Final completion:** 2021-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04162314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04162314, "Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Non-infectious and Idiopathic Uveitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04162314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*